Last updated: April 2, 2024
Sponsor: Beth Israel Deaconess Medical Center
Overall Status: Active - Recruiting
Phase
N/A
Condition
Osteoporosis
Treatment
bupivacaine
ultra-sound guide
morphine
Clinical Study ID
NCT02381717
2014P000304
Ages 18-101 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patients over 18 years of age presenting to the ED with radiographically establishedintra-, extracapsular hip fracture, able to consent and participate in the study andwho have moderate to severe pain (numerical pain score >= 31) at the time ofenrollment.
Exclusion
Exclusion Criteria:
- Patients with a previous history of hypersensitivity to local anesthetics,
- Patients who have signs of a local infection at the site of planned needle placement.
- INR > 1.4NOAC use within 48 hours
- Prophylactic Low-Molecular Weight Heparin (LMWH) within 12 hours
- Therapeutic LMWH within 24 hours
- Prophylactic Unfractionated Heparin (5000 Units BID or TID) within 6 hours
Study Design
Total Participants: 60
Treatment Group(s): 3
Primary Treatment: bupivacaine
Phase:
Study Start date:
August 01, 2015
Estimated Completion Date:
December 31, 2026
Study Description
Connect with a study center
Beth Israel Deaconess Medical Center
Boston, Massachusetts 02215
United StatesActive - Recruiting
St. Vincent's Hospital
Worcester, Massachusetts 01608
United StatesCompleted
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.